Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo

被引:202
作者
Hartlapp, I
Abe, R
Saeed, RW
Peng, T
Voelter, W
Bucala, R
Metz, CN
机构
[1] Picower Inst Med Res, Lab Vasc Biol, Manhasset, NY 11030 USA
[2] Univ Tubingen, Tubingen, Germany
关键词
fibroblast; antigen; MMP-9; wound healing; neovascularization;
D O I
10.1096/fj.01-0049com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiogenesis is an ordered process requiring the inter-play of numerous cellular and humoral factors. Studies over the past 20 years have identified several growth factors, cytokines, and enzymes that promote blood vessel formation. Most have revealed how individual factors promote an angiogenic phenotype in endothelial cells in vitro or contribute to blood vessel formation in vivo. However, the fundamental question that remains unanswered is how the cellular microenvironment contributes to angiogenesis. Fibrocytes are a recently characterized mesenchymal cell type isolated from peripheral blood that rapidly enter subcutaneously implanted wound chambers and sites of tissue injury. Here we describe the induction of an angiogenic phenotype in microvascular endothelial cells in vitro and promotion of angiogenesis in vivo by cultured fibrocytes. Fibrocytes constitutively secrete extracellular matrix-degrading enzymes, primarily matrix metalloproteinase 9, which promotes endothelial cell invasion. In addition, fibrocytes secrete several proangiogenic factors including VEGF, bFGF, IL-8, PDGF, and hematopoietic growth factors that promote endothelial cell migration, proliferation, and/or tube formation. By contrast, they do not produce representative antiangiogenic factors. Finally, both autologous fibrocytes and fibrocyte-conditioned media were found to induce blood vessel formation in vivo using the Matrigel angiogenesis model.
引用
收藏
页码:2215 / 2224
页数:10
相关论文
共 38 条
  • [31] Riedel F, 2000, HEAD NECK-J SCI SPEC, V22, P183, DOI 10.1002/(SICI)1097-0347(200003)22:2<183::AID-HED11>3.0.CO
  • [32] 2-R
  • [33] COMPARISON OF INVITRO ANTICANCER-DRUG-SCREENING DATA GENERATED WITH A TETRAZOLIUM ASSAY VERSUS A PROTEIN ASSAY AGAINST A DIVERSE PANEL OF HUMAN TUMOR-CELL LINES
    RUBINSTEIN, LV
    SHOEMAKER, RH
    PAULL, KD
    SIMON, RM
    TOSINI, S
    SKEHAN, P
    SCUDIERO, DA
    MONKS, A
    BOYD, MR
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (13) : 1113 - 1118
  • [34] SALO T, 1994, LAB INVEST, V70, P176
  • [35] ACTIONS OF TNF AND IFN-GAMMA ON ANGIOGENESIS INVITRO
    SATO, N
    NARIUCHI, H
    TSURUOKA, N
    NISHIHARA, T
    BEITZ, JG
    CALABRESI, P
    FRACKELTON, AR
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (06) : S85 - S89
  • [36] Synergism of hemopoietic growth factors on endothelial cell proliferation
    Sigounas, G
    Steiner, M
    Anagnostou, A
    [J]. ANGIOLOGY, 1997, 48 (02) : 141 - 147
  • [37] Slaton JW, 1999, CLIN CANCER RES, V5, P2726
  • [38] MACROPHAGES AND ANGIOGENESIS
    SUNDERKOTTER, C
    STEINBRINK, K
    GOEBELER, M
    BHARDWAJ, R
    SORG, C
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 55 (03) : 410 - 422